Skip to main content
Log in

Potential agents for cancer and obesity treatment with herbal medicines from the green garden

  • Review Paper
  • Published:
Biotechnology and Bioprocess Engineering Aims and scope Submit manuscript

Abstract

Many classes of bioactive drug-like molecules derived from traditional herbal plants are becoming attractive as alternative medicines for the treatment of severe chronic diseases such as cancer and obesity. A set of chemically synthesized drugs that is capable of both inhibiting cancer growth and reducing body weight for treatment of obesity have severe side effects including nausea, vomiting, diarrhea as well as producing increased blood pressure and headache, respectively. For decades, drug candidates from herbal plants have been considered as potential therapeutic agents because they are generally safer, less toxic, and have fewer lethal side effects than chemically synthesized or semi-synthetic drugs. Understanding the key factors affecting pharmacological effects and clinical outcomes has been a critical theme of natural product research. However, standardized sample preparation methods, well-controlled scientific studies, and validation studies are needed before herbal therapeutics can be introduced into the global market. This review will address the current advances in using traditional herbal plants, including the pharmacological effects and the challenges faced during the development of new drugs. The safety issues associated with toxicity and the effectiveness of the herbs in specific diseases such as cancer and obesity are also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Chang, J. (2000) Medicinal herbs: Drugs or dietary supplements. Biochem. Pharmacol. 59: 211–219.

    Article  CAS  Google Scholar 

  2. Han, S. Y. and P. P. Li (2009) Progress of research in antitumor mechanisms with Chinese medicine. Chin. J. Integr. Med. 15: 316–320.

    Article  Google Scholar 

  3. Ceylan-Isik, A. F., R. M. Fliethman, L. E. Wold, and J. Ren (2008) Herbal and traditional Chinese medicine for the treatment of cardiovascular complications in diabetes mellitus. Curr. Diabetes Rev. 4: 320–328.

    Article  CAS  Google Scholar 

  4. Kennedy, D. A. and D. Seely (2010) Clinically based evidence of drug-herb interactions: a systematic review. Expert Opin. Drug Saf. 9: 79–124.

    Article  CAS  Google Scholar 

  5. Wang, J. F., D. Q. Wei, and K. C. Chou (2008) Drug candidates from traditional Chinese medicines. Curr. Top. Med. Chem. 8: 1656–1665.

    Article  CAS  Google Scholar 

  6. Yoshida, T., N. Sakane, Y. Wakabayashi, T. Umekawa, and M. Kondo (1995) Thermogenic, anti-obesity effects of bofu-tsushosan in MSG-obese mice. Int. J. Obes. Relat. Metab. Disord. 19: 717–722.

    CAS  Google Scholar 

  7. Grothaus, P. G. and D. J. Newman (2009) Impact of natural products on developing new anti-cancer agents. Chem. Rev. 109: 3012–3043.

    Article  Google Scholar 

  8. Tapsell, L. C., I. Hemphill, L. Cobiac, C. S. Patch, D. R. Sullivan, M. Fenech, S. Roodenrys, J. B. Keogh, P. M. Clifton, P. G. Williams, V. A. Fazio, and K. E. Inge (2006) Health benefits of herbs and spices: The past, the present, the future. Med. J. Aust. 185: 4–24.

    Google Scholar 

  9. Evans, F. J. (1991) Natural products as probes for new drug target identification. J. Ethnopharmacol. 32: 91–101.

    Article  CAS  Google Scholar 

  10. Sardari, S., M. A. Shokrgozar, and G. Ghavami (2009) Cheminformatics based selection and cytotoxic effects of herbal extracts. Toxicol. In Vitro 23: 1412–1421.

    Article  CAS  Google Scholar 

  11. Wang, J., R. van der Heijden, S. Spruit, T. Hankermeier, K. Chan, J. van der Greef, G. Xu, and M. Wang (2009) Quality and safety of Chinese herbal medicines guided by a systems biology perspective. J. Ethnopharmacol. 126: 31–41.

    Article  Google Scholar 

  12. Bent, S. (2008) Herbal medicine in the United States: Review of efficacy, safety, and regulation. J. Gen. Intern. Med. 23: 854–859.

    Article  Google Scholar 

  13. Hudson, J. and M. Altamirano (2006) The application of DNA micro-arrays (gene arrays) to the study of herbal medicines. J. Ethnopharmacol. 108: 2–15.

    Article  CAS  Google Scholar 

  14. Tian, H., L. Ip, H. Luo, D. C. Chang, and K. Q. Luo (2007) A high throughput drug screen based on fluorescence resonance energy transfer (FRET) for anticancer activity of compounds from herbal medicine. Br. J. Pharmacol. 150: 321–334.

    Article  CAS  Google Scholar 

  15. Huang, Q., G. Lu, H. M. Shen, M. C. Chung, and C. N. Ong (2007) Anti-cancer properties of anthraquinones from rhubarb. Med. Res. Rev. 27: 609–630.

    Article  CAS  Google Scholar 

  16. Tayarani-Najaran, Z., S. H. Mousavi, J. Asili, and S. A. Emami (2010) Growth-inhibitory effect of Scutellaria lindbergii in human cancer cell lines. Food Chem. Toxicol. 48: 599–604.

    Article  CAS  Google Scholar 

  17. Kim, E. J., Y. -J. Lee, H. -K. Shin, and J. H. Y. Park (2005) Induction of apoptosis by the aqueous extract of Rubus coreanum in HT-29 human colon cancer cells. Nutrition 21: 1141–1148.

    Article  Google Scholar 

  18. Kim, S. M., S. Y. Lee, D. Y. Yuk, D. C. Moon, S. S. Choi, Y. Kim, S. B. Han, K. W. Oh, and J. T. Hong (2009) Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Arch. Pharm. Res. 32: 755–765.

    Article  CAS  Google Scholar 

  19. Efferth, T., P. C. H. Li, V. S. B. Konkimalla, and B. Kaina (2007) From traditional Chinese medicine to rational cancer therapy. Trends Mol. Med. 13: 353–361.

    Article  CAS  Google Scholar 

  20. Kummalue, T. (2005) Molecular mechanism of herbs in human lung cancer cells. J. Med. Assoc. Thai. 88: 1725–1734.

    Google Scholar 

  21. Li, W. Y., S. W. Chan, D. J. Guo, M. K. Chung, T. Y. Leung, and P. H. Yu (2009) Water extract of Rheum officinale Baill. induces apoptosis in human lung adenocarcinoma A549 and human breast cancer MCF-7 cell lines. J. Ethnopharmacol. 124: 251–256.

    Article  Google Scholar 

  22. Jemal, A., R. Siegel, J. Xu, and E. Ward (2010) Cancer statistics. CA. Cancer J. Clin. 60: 277–300.

    Article  Google Scholar 

  23. Sandler, A., R. Gray, M. C. Perry, J. Brahmer, J. H. Schiller, A. Dowlati, R. Lilenbaum, and D. H. Johnson (2006) Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N. Engl. J. Med. 355: 2542–2550.

    Article  CAS  Google Scholar 

  24. Magesh, V., J.-C. Lee, K. S. Ahn, H.-J. Lee, H.-J. Lee, E.-O. Lee, B. S. Shim, H. J. Jung, J. S. Kim, D. K. Kim, S.-H. Choi, K.-S. Ahn, and S.-H. Kim (2009) Ocimum sanctum induces apoptosis in A549 lung cancer cells and suppresses the in vivo growth of Lewis lung carcinoma cells. Phytother. Res. 23: 1385–1391.

    Article  CAS  Google Scholar 

  25. Yin, X., J. Zhou, C. Jie, D. Xing, and Y. Zhang (2004) Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549. Life Sci. 75: 2233–2244.

    Article  CAS  Google Scholar 

  26. Park, D. I., H. Y. Choi, C. W. Kam, C. Park, T. H. Choi, W. H. Lee, and Y. H. Choi (2004) Wikyungtang inhibits proliferation of A549 human lung cancer cells via inducing apoptosis and suppressing cyclooxygenase-2 activity. Oncol. Rep. 11: 853–856.

    CAS  Google Scholar 

  27. Li, Y. M., Y. Ohno, S. Minatoguchi, K. Fukuda, T. Ikoma, T. Ohno, S. Akao, G. Takemura, K. Gotou, and H. Fujiwara (2003) Extracts from the roots of Lindera strychifolia induces apoptosis in lung cancer cells and prolongs survival of tumor-bearing mice. Am. J. Chin. Med. 31: 857–869.

    Article  Google Scholar 

  28. Gao, J. L., T. C. He, Y. B. Li, and Y. T. Wang (2009) A traditional Chinese medicine formulation consisting of Rhizoma Corydalis and Rhizoma Curcumae exerts synergistic anti-tumor activity. Oncol. Rep. 22: 1077–1083.

    CAS  Google Scholar 

  29. Lee, H., Y. Kim, I. Choi, B. S. Min, and S. H. Shim (2010) Two novel neo-clerodane diterpenoids from Scutellaria barbata. Bioorg. Med. Chem. Lett. 20: 288–290.

    Article  CAS  Google Scholar 

  30. Lee, J. -W., Y. Kobayashi, Y. Nakamichi, N. Udagawa, N. Takahashi, N. -K. Im, H. -J. Seo, W. B. Jeon, T. Yonezawa, B. -Y. Cha, and J. -T. Woo (2010) Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice. Biochem. Pharmacol. 80: 352–361.

    Article  CAS  Google Scholar 

  31. So, F. V., N. Guthrie, A. F. Chambers, and K. K. Carroll (1997) Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett. 112: 127–133.

    Article  CAS  Google Scholar 

  32. Lu, Q., P. Zhang, X. Zhang, and J. Chen (2009) Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer. Int. J. Mol. Med. 24: 773–780.

    Article  CAS  Google Scholar 

  33. Ali, S., L. Buluwela, and R. C. Coombes (2010) Antiestrogens and their therapeutic applications in breast cancer and other diseases. Annu. Rev. Med. 18: 217–232.

    Google Scholar 

  34. Kang, J. X., J. Liu, J. Wang, C. He, and F. P. Li (2005) The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon-beta and TNF-alpha in human breast cancer cells. Carcinogenesis 26: 1934–1939.

    Article  CAS  Google Scholar 

  35. Wu, J., Y. Wu, and B. B. Yang (2002) Anticancer activity of Hemsleya amabilis extract. Life Sci. 71: 2161–2170.

    Article  CAS  Google Scholar 

  36. Zhang, D. Y., J. Wu, F. Ye, L. Xue, S. Jiang, J. Yi, W. Zhang, H. Wei, M. Sung, W. Wang, and X. Li (2003) Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria Baicalensis. Cancer Res. 63: 4037–4043.

    CAS  Google Scholar 

  37. Tang, Y. J., J. S. Yang, C. F. Lin, W. C. Shyu, M. Tsuzuki, C. C. Lu, Y. F. Chen, and K. C. Lai (2009) Houttuynia cordata Thunb extract induces apoptosis through mitochondrial-dependent pathway in HT-29 human colon adenocarcinoma cells. Oncol. Rep. 22: 1051–1056.

    CAS  Google Scholar 

  38. Gangadhar, T. and R. L. Schilsky (2010) Molecular markers to individualize adjuvant therapy for colon cancer. Nat. Rev. Clin. Oncol. 7: 318–325.

    Article  CAS  Google Scholar 

  39. Lee, S. Y., G. T. Kim, S. H. Roh, J. S. Song, H. J. Kim, S. S. Hong, S. W. Kwon, and J. H. Park (2009) Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines. Biosci. Biotechnol. Biochem. 73: 811–816.

    Article  CAS  Google Scholar 

  40. Su, C. C., G. W. Chen, J. C. Kang, and M. H. Chan (2008) Growth inhibition and apoptosis induction by tanshinone IIA in human colon adenocarcinoma cells. Planta Med. 74: 1357–1362.

    Article  CAS  Google Scholar 

  41. Lee, S. H., H. S. Hwang, and J. W. Yun (2009) Antitumor activity of water extract of a mushroom, Inonotus obliquus, against HT-29 human colon cancer cells. Phytother. Res. 23: 1784–1789.

    Article  Google Scholar 

  42. Lee, S. Y., G. T. Kim, S. H. Roh, J. S. Song, H. J. Kim, S. S. Hong, S. W. Kwon, and J. H. Park (2009) Proteome changes related to the anti-cancer activity of HT29 cells by the treatment of ginsenoside Rd. Pharmazie. 64: 242–247.

    CAS  Google Scholar 

  43. Cui, X., Y. Jin, D. Poudyal, A. A. Chumanevich, T. Davis, A. Windust, A. Hofseth, W. Wu, J. Habiger, E. Pena, P. Wood, M. Nagarkatti, P. S. Nagarkatti, and L. Hofseth (2010) Mechanistic insight into the ability of American ginseng to suppress colon cancer associated with colitis. Carcinogenesis 31: 1734–1741.

    Article  CAS  Google Scholar 

  44. Min, J. K., J. H. Kim, Y. L. Cho, Y. S. Maeng, S. J. Lee, B. J. Pyun, Y. M. Kim, J. H. Park, and Y. G. Kwon (2006) 20(S)-Ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway. Biochem. Biophys. Res. Commun. 349: 987–994.

    Article  CAS  Google Scholar 

  45. Cook, T. and W. P. Sheridan (2000) Development of GnRH antagonists for prostate cancer: New approaches to treatment. Oncologist 5: 162–168.

    Article  CAS  Google Scholar 

  46. Bonham, M., J. Posakony, I. Coleman, B. Montgomery, J. Simon, and P. S. Nelson (2005) Characterization of chemical constituents in Scutellaria baicalensis with antiandrogenic and growth-inhibitory activities toward prostate carcinoma. Clin. Cancer Res. 11: 3905–3914.

    Article  CAS  Google Scholar 

  47. Bonham, M., H. Arnold, B. Montgomery, and P. S. Nelson (2002) Molecular effects of the herbal compound PC-SPES: Identification of activity pathways in prostate carcinoma. Cancer Res. 62: 3920–3924.

    CAS  Google Scholar 

  48. Taniguchi, H., T. Yoshida, M. Horinaka, T. Yasuda, A. E. Goda, M. Konishi, M. Wakada, K. Kataoka, T. Yoshikawa, and T. Sakai (2008) Baicalein overcomes tumor necrosis factor-related apoptosis- inducing ligand resistance via two different cell-specific pathways in cancer cells but not in normal cells. Cancer Res. 68: 8918–8927.

    Article  CAS  Google Scholar 

  49. Gohil, K. (2002) Genomic responses to herbal extracts: lessons from in vitro and in vivo studies with an extract of Ginkgo biloba. Biochem. Pharmacol. 64: 913–917.

    Article  CAS  Google Scholar 

  50. Parmentier-Batteur, S., K. Jin, L. Xie, X. O. Mao, and D. A. Greenberg (2002) DNA microarray analysis of cannabinoid signaling in mouse brain in vivo. Mol. Pharmacol. 62: 828–835.

    Article  CAS  Google Scholar 

  51. Kim, S. W., S. C. Choi, E. Y. Choi, K. S. Kim, J. M. Oh, H. J. Lee, H. M. Oh, S. Kim, B. S. Oh, K. C. Kimm, M. H. Lee, G. S. Seo, T. H. Kim, H. C. Oh, W. H. Woo, Y. S. Kim, H. O. Pae, D. S. Park, H. T. Chung, and C. D. Jun (2004) Catalposide, a compound isolated from catalpa ovata, attenuates induction of intestinal epithelial proinflammatory gene expression and reduces the severity of trinitrobenzene sulfonic Acid-induced colitis in mice. Inflamm. Bowel Dis. 10: 564–572.

    Article  Google Scholar 

  52. Lee, S. M., M. L. Li, Y. C. Tse, S. C. Leung, M. M. Lee, S. K. Tsui, K. P. Fung, C. Y. Lee, and M. M. Waye (2002) Paeoniae Radix, a Chinese herbal extract, inhibit hepatoma cells growth by inducing apoptosis in a p53 independent pathway. Life Sci. 71: 2267–2277.

    Article  CAS  Google Scholar 

  53. Zhuang, W. J., C. C. Fong, J. Cao, L. Ao, C. H. Leung, H. Y. Cheung, P. G. Xiao, W. F. Fong, and M. S. Yang (2004) Involvement of NF-kappaB and c-myc signaling pathways in the apoptosis of HL-60 cells induced by alkaloids of Tripterygium hypoglaucum (levl.) Hutch. Phytomed. 11: 295–302.

    Article  CAS  Google Scholar 

  54. Yang, N. S., L. F. Shyur, C. H. Chen, S. Y. Wang, and C. M. Tzeng (2004) Medicinal herb extract and a single-compound drug confer similar complex pharmacogenomic activities in MCF-7 cells. J. Biomed. Sci. 11: 418–422.

    Article  CAS  Google Scholar 

  55. Ye, F., S. Jiang, H. Volshonok, J. Wu, and D. Y. Zhang (2007) Molecular mechanism of anti-prostate cancer activity of Scutellaria baicalensis extract. Nutr. Cancer. 57: 100–110.

    Article  CAS  Google Scholar 

  56. Huang, Y. -T., D. -M. Huang, S. -C. Chueh, C. -M. Teng, and J. - H. Guh (2006) Alisol B acetate, a triterpene from Alismatis rhizoma, induces Bax nuclear translocation and apoptosis in human hormone-resistant prostate cancer PC-3 cells. Cancer Lett. 231: 270–278.

    Article  CAS  Google Scholar 

  57. Huang, S. T., R. C. Yang, P. N. Lee, S. H. Yang, S. K. Liao, T. Y. Chen, and J. H. Pang (2006) Anti-tumor and anti-angiogenic effects of Phyllanthus urinaria in mice bearing Lewis lung carcinoma. Int. Immunopharmacol. 6: 870–879.

    Article  CAS  Google Scholar 

  58. Xu, Y. H., L. J. Zhao, and Y. Li (2009) Alisol B acetate induces apoptosis of SGC7901 cells via mitochondrial and phosphatidylinositol 3-kinases/Akt signaling pathways. World J. Gastroenterol. 15: 2870–2877.

    Article  CAS  Google Scholar 

  59. Li, W. L., H. C. Zheng, J. Bukuru, and N. De Kimpe (2004) Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J. Ethnopharmacol. 92: 1–21.

    Article  CAS  Google Scholar 

  60. Yun, J. W. (2010) Possible anti-obesity therapeutics from nature — A review. Phytochem. 71: 1625–1641.

    Article  CAS  Google Scholar 

  61. McClendon, K. S., D. M. Riche, and G. I. Uwaifo (2009) Orlistat: Current status in clinical therapeutics. Expert Opin. Drug Saf. 8: 727–744.

    CAS  Google Scholar 

  62. Ballinger, A. and S. R. Peikin (2002) Orlistat: Its current status as an anti-obesity drug. Eur. J. Pharmacol. 440: 109–117.

    Article  CAS  Google Scholar 

  63. Joo, J. I., D. H. Kim, and J. W. Yun (2010) Extract of Chaga mushroom (Inonotus obliquus) stimulates 3t3-l1 adipocyte differentiation. Phytother. Res. 24: 1592–1599.

    Article  Google Scholar 

  64. Nakayama, T., S. Suzuki, H. Kudo, S. Sassa, M. Nomura, and S. Sakamoto (2007) Effects of three Chinese herbal medicines on plasma and liver lipids in mice fed a high-fat diet. J. Ethnopharmacol. 109: 236–240.

    Article  Google Scholar 

  65. Lemaure, B., A. Touche, I. Zhinden, J. Moulin, D. Courtois, K. Mace, and C. Darimont (2007) Administration of Cyperus rotundus tubers extract prevents weight gain in obese Zucker rats. Phytother. Res. 21: 724–730.

    Article  Google Scholar 

  66. Zhen, Y., H. Qi, N. Hai Xiang, and W. Dong (2008) Cortex Lycii Radicis extracts improve insulin resistance and lipid metabolism in obese-diabetic rats. Phytother. Res. 22: 1665–1670.

    Article  Google Scholar 

  67. Kang, M., J. W. Oh, H. K. Lee, H. S. Chung, S. M. Lee, C. Kim, H. J. Lee, D. W. Yoon, H. Choi, H. Kim, M. Shin, M. Hong, and H. Bae (2004) Anti-obesity effect of PM-F2-OB, an anti-obesity herbal formulation, on rats fed a high-fat diet. Biol. Pharm. Bull. 27: 1251–1256.

    Article  CAS  Google Scholar 

  68. Han, L. K., Y. N. Zheng, M. Yoshikawa, H. Okuda, and Y. Kimura (2005) Anti-obesity effects of chikusetsusaponins isolated from Panax japonicus rhizomes. BMC Complement Altern Med. 5: 9.

    Article  Google Scholar 

  69. Dou, D. Q., Y. J. Chen, L. H. Liang, F. G. Pang, N. Shimizu, and T. Takeda (2001) Six new dammarane-type triterpene saponins from the leaves of Panax ginseng. Chem. Pharm. Bull. (Tokyo). 49: 442–446.

    Article  CAS  Google Scholar 

  70. Chizuko, H., Y. Kanji, and Y. Toshihide (2004) Efficacy of Bofutsusho- san, an oriental herbal medicine, in obese Japanese women with impaired glucose tolerance. Clin. Exp. Pharmacol. Physiol. 31: 614–619.

    Article  Google Scholar 

  71. Boozer, C. N., J. A. Nasser, S. B. Heymsfield, V. Wang, G. Chen, and J. L. Solomon (2001) A herbal supplement containing Ma Huang-Guarana for weight loss: A randomized, double-blind trial. Int. J. Obes. Relat. Metab. Disord. 25: 316–324.

    Article  CAS  Google Scholar 

  72. Oben, J. E., D. M. Enyegue, G. I. Fomekong, Y. B. Soukontoua, and G. A. Agbor (2007) The effect of Cissus quadrangularis (CQR-300) and a Cissus formulation (CORE) on obesity and obesity-induced oxidative stress. Lipids Health Dis. 6: 4.

    Article  Google Scholar 

  73. Oben, J. E., J. L. Ngondi, C. N. Momo, G. A. Agbor, and C. S. Sobgui (2008) The use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: A double-blind placebo-controlled study. Lipids Health Dis. 7: 12.

    Article  Google Scholar 

  74. Chen, Y. Y., J. F. Liu, C. M. Chen, P. Y. Chao, and T. J. Chang (2003) A study of the antioxidative and antimutagenic effects of Houttuynia cordata Thunb. using an oxidized frying oil-fed model. J. Nutr. Sci. Vitaminol. (Tokyo). 49: 327–333.

    Article  CAS  Google Scholar 

  75. Chen, X. Y., T. X. Wu, G. J. Liu, Q. Wang, J. Zheng, J. Wei, J. Ni, L. K. Zhou, X. Duan, and J. Q. Qiao (2007) Chinese medicinal herbs for influenza. Cochrane Database Syst. Rev. CD004559.

  76. Fu, T. T., J. Y. Wu, L. Wang, Y. Ma, Y. Wang, Y. Liu, and H. Ding (2006) Study on the Chinese herbal formula for treatment of vaginitis and the antimicrobial activity in murine models. Zhong Yao Cai. 29: 931–936.

    Google Scholar 

  77. Yuan, R. and Y. Lin (2000) Traditional Chinese medicine: An approach to scientific proof and clinical validation. Pharmacol. Ther. 86: 191–198.

    Article  CAS  Google Scholar 

  78. Waters, M. D. and J. M. Fostel (2004) Toxicogenomics and systems toxicology: Aims and prospects. Nat. Rev. Genet. 5: 936–948.

    Article  CAS  Google Scholar 

  79. Newman, D. J. and G. M. Cragg (2007) Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 70: 461–477.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jong Pil Park.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, J.P., Kim, J.H., Park, M.K. et al. Potential agents for cancer and obesity treatment with herbal medicines from the green garden. Biotechnol Bioproc E 16, 1065–1076 (2011). https://doi.org/10.1007/s12257-011-0215-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12257-011-0215-3

Keywords

Navigation